EverEx
EverEx is dedicated to providing personalized musculoskeletal rehabilitation solutions using artificial intelligence technology. They aim to improve treatment accessibility and effectiveness through innovative digital solutions, clinical trials, and global partnerships. Recognized with awards such as CES 2024 Innovation Award and design accolades, EverEx is committed to building a healthier world where rehabilitation is easy and personalized, anytime and anywhere.
Industries
Nr. of Employees
small (1-50)
EverEx
Seoul, Gangnam-gu, Gangnam-daero 94-gil 10, K Square 7th Floor, EverEx
Products
Remote therapeutic monitoring platform (FDA Class II registered)
A remote rehabilitation monitoring platform that delivers personalized exercise programs from a large exercise video library and supports remote clinician monitoring; registered as a Class II device in the U.S.
AI-powered musculoskeletal motion analysis software (MFDS Class II)
Computer vision–based motion analysis software intended for clinical musculoskeletal assessment; certified as a Class II medical device by Korea’s regulatory authority.
Personalized rehabilitation program platform
Platform that creates individualized musculoskeletal rehabilitation programs using a multi‑thousand video library and exercise performance data to improve adherence.
Enterprise musculoskeletal health service
AI‑driven musculoskeletal care service for employees that pairs individualized rehab content with specialist oversight and reporting.
Digital therapeutic for musculoskeletal disorders (DTx) — clinical program
A prescription digital therapeutic combining daily tailored rehabilitation exercises with cognitive behavioral therapy elements; undergoing clinical trials including a pivotal IDE‑approved study.
Remote therapeutic monitoring platform (FDA Class II registered)
A remote rehabilitation monitoring platform that delivers personalized exercise programs from a large exercise video library and supports remote clinician monitoring; registered as a Class II device in the U.S.
AI-powered musculoskeletal motion analysis software (MFDS Class II)
Computer vision–based motion analysis software intended for clinical musculoskeletal assessment; certified as a Class II medical device by Korea’s regulatory authority.
Personalized rehabilitation program platform
Platform that creates individualized musculoskeletal rehabilitation programs using a multi‑thousand video library and exercise performance data to improve adherence.
Enterprise musculoskeletal health service
AI‑driven musculoskeletal care service for employees that pairs individualized rehab content with specialist oversight and reporting.
Digital therapeutic for musculoskeletal disorders (DTx) — clinical program
A prescription digital therapeutic combining daily tailored rehabilitation exercises with cognitive behavioral therapy elements; undergoing clinical trials including a pivotal IDE‑approved study.
Services
Onboarding and integration services to deploy AI motion analysis and remote monitoring tools in clinical settings.
Provision of AI musculoskeletal health and rehabilitation services tailored for company employees, including 1:1 specialist care and data reports.
Service to remotely monitor patient rehabilitation adherence and performance, enabling clinicians to manage remote treatment and associated billing pathways.
Onboarding and integration services to deploy AI motion analysis and remote monitoring tools in clinical settings.
Provision of AI musculoskeletal health and rehabilitation services tailored for company employees, including 1:1 specialist care and data reports.
Service to remotely monitor patient rehabilitation adherence and performance, enabling clinicians to manage remote treatment and associated billing pathways.
Expertise Areas
- Digital therapeutics for musculoskeletal disorders
- AI/ML model development for motion analysis
- Software-as-a-medical-device (SaMD) engineering
- Remote therapeutic monitoring and tele‑rehabilitation
Key Technologies
- Computer vision–based pose estimation
- Machine learning for motion analysis
- Personalized exercise prescription algorithms
- Digital therapeutics platforms combining CBT
News & Updates
CES 2024 참가
EverEx participated in CES 2024.
MORA Vu 의료기기 인증
MORA Vu certified as a Class II medical device for Musculoskeletal Analysis Software.
iF 디자인 어워드 수상
EverEx received the iF Design Award 2024.
MORA Cure 임상 승인
MORA Cure (PFPS) received IDE approval for pivotal clinical trial.
미국 K-스타트업센터 입주
Selected as a located company for the U.S. K-Startup Center.
RedDot 및 K-디자인 어워드 수상
EverEx won the RedDot and K-Design Awards in 2024.
CES 2024 참가
EverEx participated in CES 2024.
MORA Vu 의료기기 인증
MORA Vu certified as a Class II medical device for Musculoskeletal Analysis Software.
iF 디자인 어워드 수상
EverEx received the iF Design Award 2024.
MORA Cure 임상 승인
MORA Cure (PFPS) received IDE approval for pivotal clinical trial.
미국 K-스타트업센터 입주
Selected as a located company for the U.S. K-Startup Center.
RedDot 및 K-디자인 어워드 수상
EverEx won the RedDot and K-Design Awards in 2024.